Tag: Nasdaq:CLSD

- XIPERE Now Approved for Use in Multiple Global Markets -

- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications -

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:CLSD